Check our latest news and where we are going to be soon.
Biohope Welcomes Nuria de Pedro as R&D Director
Biohope is delighted to announce the appointment of Nuria de Pedro, PhD, as the new Research and Development (R&D) Director. With 25 years of extensive experience in the pharmaceutical and biotech industries, she brings a wealth of [...]
Pilar Najarro joins Biohope as Managing Director
Biohope is thrilled to announce the latest addition to our dynamic team. Dr. Pilar Najarro, a distinguished professional with a rich background in Health and Biotech, has joined us as Managing Director. Pilar's journey in the field [...]
Isabel Portero presents Immunobiogram for Renal Transplant at the 3rd edition of “Future of Transplantation meeting” organized by AST in Boston
Our CEO, Isabel Portero, took stage at the 3rd edition of the "Future of Transplantation Meeting" organized by the American Society of Transplantation (AST) in Boston, where she presented the groundbreaking Immunobiogram for Renal Transplant. Dedicated [...]
Results from IMBITRA clinical study have been presented at the 53rd SEN Congress 2023
Results from IMBITRA study of Immunobiogram in renal transplant patients in maintenance phase have been presented at the 53rd SEN Congress 2023, which took place in Palma de Mallorca on November 11th - 13th. IMBITRA study [...]
Biohope Receives CDTI Grant for Development of In Vitro Test to Monitor Autoimmune Diseases
Biohope, a leading company in personalized medicine, has been awarded a grant by the Center for the Development of Industrial Technology (CDTI) to support its project titled "Development of a Cellular Assay for Monitoring Autoimmune Diseases" (Project [...]
Biohope presents results of novel IVD solution in Rheumatoid Arthritis at EULAR Congress 2023
Biohope has presented a poster with clinical study results of the novel ROS and Monocytes tests to measure in vitro the methotrexate response in early rheumatoid arthritis patients at the European Congress of Rheumatology 2023 (EULAR), [...]
New Hire: Sara Pascual joins Biohope as Access & Medical Affairs Director
We are thrilled to share that Sara Pascual just joined Biohope team as our Access & Medical Affairs Director. In this new role, Sara will lead the medical affairs and business development strategy of the company, focusing [...]
AST’s Cutting Edge of Transplantation 2023
Biohope reperesented by our CEO, Isabel Portero, participated in the CEOT 2023. American Society of Transplantation (AST) organized a new edition of "Cutting Edge of Transplantation" (CEoT) 2023 - Embracing New Frontiers in Transplantation. The event focused [...]
La sanidad española será la primera en poder ofrecer tratamientos personalizados a las personas trasplantadas de riñón
El test in-vitro Immunobiogram®, desarrollado por la biotech española Biohope, permite seleccionar la terapia más adecuada para cada paciente a partir de una muestra de sangre. Este importante avance médico se presentará en el Congreso de la [...]
52º Congreso de la Sociedad Española de Nefrología
Oral communication C Jimenez, D Valencia , Mo Lopez, Me Gonzalez, Ma Moreno, A De Santos, A Ortega, T Diez, I Portero, A Sánchez-fructuoso. “Caracterización de los parámetros del Immunobiogram, un nuevo método para la medida in [...]
